Next-Gen Healthcare Focuses on Therapies and TechOct 18, 2021
Investors zoom in on cell and gene therapies and tech platforms that can deliver better care at lower costs.
Corporations, organizations and governments around the world rely on Morgan Stanley’s reputation as a global leader in investment banking. Our advisory and capital-raising services are recognized as among the best in the industry.
Special purpose acquisition companies (SPACs) give private companies an alternative to standard initial public offerings (IPOs). A Morgan Stanley banker explains how they work and what they offer startups and investors alike.
Morgan Stanley's Mergers and Acquisitions (M&A) department devises and executes innovative, customized solutions to our clients' most challenging issues. The M&A team excels in domestic and international transactions including acquisitions, divestitures, mergers, joint ventures, corporate restructurings, recapitalizations, spin-offs, exchange offers, leveraged buyouts and takeover defenses as well as shareholder relations. Morgan Stanley applies its extensive experience with global industries, regions and banking products to meet our clients' short- and long-term strategic objectives.
Morgan Stanley's Global Capital Markets (GCM) division responds with market judgments and ingenuity to clients' needs for capital. Whether executing an IPO, a debt offering or a leveraged buyout, GCM integrates our expertise in Sales and Trading and in Investment Banking to offer clients seamless advice and sophisticated solutions. We originate, structure and execute public and private placement of a variety of securities: equities, investment-grade and non-investment-grade debt and related products.
Morgan Stanley brings to its clients a deep understanding of many industries